Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy
- 1 November 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (15) , 1107-1112
- https://doi.org/10.1016/0002-9149(90)90513-z
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Physiologic mechanisms governing hemodynamic responses to positive inotropic therapy in patients with dilated cardiomyopathy.Circulation, 1988
- Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathyThe American Journal of Cardiology, 1987
- Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure.Circulation, 1986
- Comparative vasoactive therapy for heart failureThe American Journal of Cardiology, 1985
- Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.Circulation, 1984
- The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathyAmerican Heart Journal, 1983
- Dobutamine and hydralazine: Comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failureJournal of the American College of Cardiology, 1983
- Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery diseaseEuropean Heart Journal, 1982
- Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failureThe American Journal of Cardiology, 1981
- Tolerance to dobutamine after a 72 hour continuous infusionThe American Journal of Medicine, 1980